{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T17:53:31Z","timestamp":1755798811454,"version":"3.44.0"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To review the literature on vitreous analysis in eyes with concurrent rhegmatogenous retinal and choroidal detachment (RRD-CD).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A comprehensive literature search was performed from January 2000 through December 2023 for \u201crhegmatogenous retinal detachment,\u201d \u201cchoroidal detachment,\u201d and \u201cvitreous.\u201d All English language primary literature was reviewed, and seven studies were found to meet inclusion criteria. Vitreous molecules were categorized by upregulated and downregulated states in RRD-CD eyes compared with controls. The cytokines, chemokines, growth factors, metabolites, transporter molecules, and other plasma proteins\/lipids in the vitreous samples were evaluated in a systematic format to identify pathophysiologic processes involved.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Mass spectrometry and immunoassays were most commonly used for evaluation. Notable dysregulation of the complement cascade (C3a and C5a), immunologic response (soluble intercellular adhesion molecule 1, IL-1B, and cellular metabolites), and major inflammatory mediators (migration inhibitor factor and IL-6) was identified and may serve as salient targets. Intravitreal and systemic agents have had mixed success in treating RRD-CD. Utilization of existing modalities and targeting novel factors have not been fully evaluated in RRD-CD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Identification of alterations in levels of vitreous proteins in RRD-CD cases compared with controls highlights disease pathophysiology. Clinical targets exist and additional studies are warranted to improve management of this condition.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000004565","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T16:00:21Z","timestamp":1751040021000},"page":"1631-1639","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["VITREOUS PROTEOME IN COMBINED RHEGMATOGENOUS RETINAL AND CHOROIDAL DETACHMENT"],"prefix":"10.1097","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1641-1890","authenticated-orcid":false,"given":"Neeket R.","family":"Patel","sequence":"first","affiliation":[{"name":"Institute of Ophthalmology and Visual Science, Rutgers New Jersey Medical School, Newark, NJ;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander J.","family":"Brucker","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Scheie Eye Institute, Perelman School of Medicine at University of Pennsylvania, Philadelphia, PA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton M.","family":"Kolomeyer","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Scheie Eye Institute, Perelman School of Medicine at University of Pennsylvania, Philadelphia, PA;"},{"name":"NJ Retina (PRISM Vision Group), New Providence, NJ; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3186-6267","authenticated-orcid":false,"given":"Jonathan C.","family":"Tsui","sequence":"additional","affiliation":[{"name":"Institute of Ophthalmology and Visual Science, Rutgers New Jersey Medical School, Newark, NJ;"},{"name":"Department of Ophthalmology, Scheie Eye Institute, Perelman School of Medicine at University of Pennsylvania, Philadelphia, PA;"},{"name":"Department of Ophthalmology, Veterans Affairs New Jersey Healthcare System, East Orange, NJ."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250819","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1001\/archopht.1974.03900060264003","article-title":"Choroidal detachment associated with primary retinal detachment","volume":"91","author":"Seelenfreund","year":"1974","journal-title":"Arch Ophthalmol"},{"key":"R2-20250819","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/archopht.1972.01000030483003","article-title":"Combined choroidal and retinal detachment","volume":"88","author":"Gottlieb","year":"1972","journal-title":"Arch Ophthalmol"},{"key":"R3-20250819","first-page":"989","article-title":"Risk factors of rhegmatogenous retinal detachment associated with choroidal detachment in Chinese patients","volume":"9","author":"Gu","year":"2016","journal-title":"Int J Ophthalmol"},{"key":"R4-20250819","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12886-016-0319-9","article-title":"Risk factors for choroidal detachment following rhegmatogenous retinal detachment in a Chinese population","volume":"16","author":"Yu","year":"2016","journal-title":"BMC Ophthalmol"},{"key":"R5-20250819","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1001\/archopht.1956.00930030244010","article-title":"Choroidal detachment in the surgical treatment of retinal separation","volume":"55","author":"Swan","year":"1956","journal-title":"AMA Arch Ophthalmol"},{"key":"R6-20250819","first-page":"664","article-title":"Rhematogenous retinal detachment complicated by severe intraocular inflammation, hypotony, and choroidal detachment","volume":"79","author":"Jarrett","year":"1981","journal-title":"Trans Am Ophthalmol Soc"},{"key":"R7-20250819","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/archopht.1997.01100150239014","article-title":"Pathogenic mechanisms in proliferative vitreoretinopathy","volume":"115","author":"Campochiaro","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"R8-20250819","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s00417-017-3673-2","article-title":"Ciliary body thickness changes after preoperative anti-inflammatory treatment in rhegmatogenous retinal detachment complicated by choroidal detachment","volume":"255","author":"Alibet","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R9-20250819","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1159\/000529451","article-title":"Steroid drugs as an adjunct for reducing the incidence of proliferative vitreoretinopathy after rhegmatogenous retinal detachment surgery: a meta-analysis of randomized controlled studies","volume":"66","author":"Xu","year":"2023","journal-title":"Ophthalmic Res"},{"key":"R10-20250819","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.ophtha.2006.08.042","article-title":"Randomized controlled trial of combined 5-Fluorouracil and low-molecular-weight heparin in the management of unselected rhegmatogenous retinal detachments undergoing primary vitrectomy","volume":"114","author":"Wickham","year":"2007","journal-title":"Ophthalmology"},{"key":"R11-20250819","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.ajpath.2013.01.052","article-title":"Ranibizumab is a potential prophylaxis for proliferative vitreoretinopathy, a nonangiogenic blinding disease","volume":"182","author":"Pennock","year":"2013","journal-title":"Am J Pathol"},{"key":"R12-20250819","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3928\/23258160-20230220-01","article-title":"Low-dose intravitreal methotrexate for proliferative vitreoretinopathy","volume":"54","author":"Ullah","year":"2023","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"R13-20250819","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0161-6420(95)31007-X","article-title":"The effect of oral 13-cis-retinoic acid on retinal redetachment after surgical repair in eyes with proliferative vitreoretinopathy","volume":"102","author":"Fekrat","year":"1995","journal-title":"Ophthalmology"},{"key":"R14-20250819","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/014107680309600304","article-title":"Five steps to conducting a systematic review","volume":"96","author":"Khan","year":"2003","journal-title":"J R Soc Med"},{"key":"R15-20250819","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1440-1797.2010.01380.x","article-title":"How to write a Cochrane systematic review","volume":"15","author":"Henderson","year":"2010","journal-title":"Nephrology (Carlton)"},{"key":"R23-20250819","first-page":"417","article-title":"Identification of inflammatory mediators in patients with rhegmatogenous retinal detachment associated with choroidal detachment","volume":"21","author":"Dai","year":"2015","journal-title":"Mol Vis"},{"key":"R17-20250819","doi-asserted-by":"crossref","first-page":"5706","DOI":"10.1167\/iovs.14-16338","article-title":"Metabolomic analysis of human vitreous in rhegmatogenous retinal detachment associated with choroidal detachment","volume":"56","author":"Yu","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R18-20250819","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.3390\/ijms17122052","article-title":"Identification of potential biomarkers for rhegmatogenous retinal detachment associated with choroidal detachment by vitreous iTRAQ-based proteomic profiling","volume":"17","author":"Wu","year":"2016","journal-title":"Int J Mol Sci"},{"key":"R21-20250819","first-page":"252","article-title":"Vitreous levels of apolipoprotein A1 and retinol binding protein 4 in human rhegmatogenous retinal detachment associated with choroidal detachment","volume":"24","author":"Ding","year":"2018","journal-title":"Mol Vis"},{"key":"R16-20250819","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s11010-022-04409-0","article-title":"Quantitative proteomics analysis of human vitreous in rhegmatogenous retinal detachment associated with choroidal detachment by data-independent acquisition mass spectrometry","volume":"477","author":"Luo","year":"2022","journal-title":"Mol Cell Biochem"},{"key":"R22-20250819","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1080\/02713683.2022.2038634","article-title":"The complement system in retinal detachment with choroidal detachment","volume":"47","author":"Luo","year":"2022","journal-title":"Curr Eye Res"},{"key":"R24-20250819","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3892\/etm.2022.11420","article-title":"The complement C3a-C3aR and C5a-C5aR pathways promote viability and inflammation of human retinal pigment epithelium cells by targeting NF-\u03baB signaling","volume":"24","author":"Luo","year":"2022","journal-title":"Exp Ther Med"},{"key":"R19-20250819","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/S0161-6420(98)91230-1","article-title":"Primary vitrectomy for rhegmatogenous retinal detachment associated with choroidal detachment","volume":"105","author":"Sharma","year":"1998","journal-title":"Ophthalmology"},{"key":"R20-20250819","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.2042-3306.1984.tb01893.x","article-title":"The acute inflammatory process, arachidonic acid metabolism and the mode of action of anti-inflammatory drugs","volume":"16","author":"Higgins","year":"1984","journal-title":"Equine Vet J"},{"key":"R25-20250819","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1046\/j.1365-2249.2003.02087.x","article-title":"Differential cytokine expression of human retinal pigment epithelial cells in response to stimulation by C5a","volume":"131","author":"Fukuoka","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"R26-20250819","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/ceo.13121","article-title":"Retinal pigment epithelium in the pathogenesis of age-related macular degeneration and photobiomodulation as a potential therapy?","volume":"46","author":"Ao","year":"2018","journal-title":"Clin Exp Ophthalmol"},{"key":"R27-20250819","doi-asserted-by":"crossref","first-page":"9679","DOI":"10.1038\/s41598-018-28143-0","article-title":"C3a triggers formation of sub-retinal pigment epithelium deposits via the ubiquitin proteasome pathway","volume":"8","author":"Fernandez-Godino","year":"2018","journal-title":"Sci Rep"},{"key":"R28-20250819","doi-asserted-by":"crossref","first-page":"31189","DOI":"10.1074\/jbc.M115.671180","article-title":"Complement component C5a primes retinal pigment epithelial cells for inflammasome activation by lipofuscin-mediated photooxidative damage","volume":"290","author":"Brandstetter","year":"2015","journal-title":"J Biol Chem"},{"key":"R29-20250819","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3928\/1542-8877-19970401-05","article-title":"Pars plana vitrectomy in the treatment of combined rhegmatogenous retinal detachment and choroidal detachment in aphakic or pseudophakic patients","volume":"28","author":"Yang","year":"1997","journal-title":"Ophthalmic Surg Lasers"},{"key":"R30-20250819","doi-asserted-by":"crossref","first-page":"107482","DOI":"10.1016\/j.compbiolchem.2021.107482","article-title":"The role of human C5a as a non-genomic target in corticosteroid therapy for management of severe COVID19","volume":"92","author":"Das","year":"2021","journal-title":"Comput Biol Chem"},{"key":"R31-20250819","doi-asserted-by":"crossref","first-page":"e0173257","DOI":"10.1371\/journal.pone.0173257","article-title":"Complement effectors, C5a and C3a, in cystic fibrosis lung fluid correlate with disease severity","volume":"12","author":"Hair","year":"2017","journal-title":"PLoS One"},{"key":"R32-20250819","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1097\/IAE.0000000000003770","article-title":"Combined rhegmatogenous retinal and choroidal detachment: a Systematic Review","volume":"43","author":"Tsui","year":"2023","journal-title":"Retina"},{"key":"R33-20250819","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.3390\/cells11213462","article-title":"Membrane attack complex mediates retinal pigment epithelium cell death in Stargardt macular degeneration","volume":"11","author":"Ng","year":"2022","journal-title":"Cells"},{"key":"R34-20250819","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1093\/brain\/awz222","article-title":"Targeting the complement system in bacterial meningitis","volume":"142","author":"Koelman","year":"2019","journal-title":"Brain"},{"key":"R35-20250819","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1016\/j.ajpath.2014.07.017","article-title":"The membrane attack complex in aging human choriocapillaris: relationship to macular degeneration and choroidal thinning","volume":"184","author":"Mullins","year":"2014","journal-title":"Am J Pathol"},{"key":"R36-20250819","first-page":"89","article-title":"Inhibition of C9 polymerization within the SC5b-9 complex of complement by S-protein","volume":"284","author":"Podack","year":"1984","journal-title":"Acta Pathol Microbiol Immunol Scand Suppl"},{"key":"R37-20250819","doi-asserted-by":"crossref","first-page":"7464","DOI":"10.1021\/bi962895r","article-title":"Potent inhibition of terminal complement assembly by clusterin: characterization of its impact on C9 polymerization","volume":"36","author":"McDonald","year":"1997","journal-title":"Biochemistry"},{"key":"R38-20250819","first-page":"91","article-title":"Soluble intercellular adhesion molecule-1 (sICAM-1): an overview","volume":"15","author":"Witkowska","year":"2004","journal-title":"Eur Cytokine Netw"},{"key":"R39-20250819","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.3389\/fimmu.2019.01618","article-title":"IL-1 family members mediate cell death, inflammation and angiogenesis in retinal degenerative diseases","volume":"10","author":"Wooff","year":"2019","journal-title":"Front Immunol"},{"key":"R40-20250819","doi-asserted-by":"crossref","first-page":"8604","DOI":"10.1016\/S0021-9258(18)93017-6","article-title":"Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression","volume":"266","author":"Rao","year":"1991","journal-title":"J Biol Chem"},{"key":"R41-20250819","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1046\/j.1523-1755.1999.00570.x","article-title":"Urea induces macrophage proliferation by inhibition of inducible nitric oxide synthesis","volume":"56","author":"Moeslinger","year":"1999","journal-title":"Kidney Int"},{"key":"R42-20250819","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1136\/bjo.85.11.1367","article-title":"Macrophage migration inhibitory factor in ocular fluids of patients with uveitis","volume":"85","author":"Taguchi","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"R43-20250819","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1111\/bcp.14289","article-title":"Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours","volume":"86","author":"Mahalingam","year":"2020","journal-title":"Br J Clin Pharmacol"},{"key":"R44-20250819","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.3109\/10428194.2015.1028052","article-title":"Phase I study of the anti-CD74 monoclonal antibody milatuzumab (hLL1) in patients with previously treated B-cell lymphomas","volume":"56","author":"Martin","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"R45-20250819","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1016\/j.drudis.2018.06.017","article-title":"Small-molecule inhibitors of macrophage migration inhibitory factor (MIF) as an emerging class of therapeutics for immune disorders","volume":"23","author":"Kok","year":"2018","journal-title":"Drug Discov Today"},{"key":"R46-20250819","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12348-023-00361-2","article-title":"Targeting macrophage migration inhibitory factor (MIF): a promising therapy for inflammatory ocular diseases","volume":"13","author":"V\u00e1zquez","year":"2023","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"R47-20250819","doi-asserted-by":"crossref","first-page":"e0194603","DOI":"10.1371\/journal.pone.0194603","article-title":"Anti-inflammatory cytokine and angiogenic factors levels in vitreous samples of diabetic retinopathy patients","volume":"13","author":"Tsai","year":"2018","journal-title":"PLoS One"},{"key":"R48-20250819","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/eye.2014.21","article-title":"Intrasilicone oil injection of bevacizumab at the end of retinal reattachment surgery for severe proliferative vitreoretinopathy","volume":"28","author":"Ghasemi Falavarjani","year":"2014","journal-title":"Eye (Lond)"},{"key":"R49-20250819","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.ophtha.2008.05.016","article-title":"Triamcinolone acetonide in silicone-filled eyes as adjunctive treatment for proliferative vitreoretinopathy: a randomized clinical trial","volume":"115","author":"Ahmadieh","year":"2008","journal-title":"Ophthalmology"},{"key":"R50-20250819","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/BF00184858","article-title":"Does the presence of heparin and dexamethasone in the vitrectomy infusate reduce reproliferation in proliferative vitreoretinopathy?","volume":"234","author":"Williams","year":"1996","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R51-20250819","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ophtha.2017.01.021","article-title":"Slow-release dexamethasone in proliferative vitreoretinopathy: a prospective, randomized controlled clinical trial","volume":"124","author":"Banerjee","year":"2017","journal-title":"Ophthalmology"},{"key":"R52-20250819","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.2147\/OPTH.S111893","article-title":"Intravitreal methotrexate infusion for proliferative vitreoretinopathy","volume":"10","author":"Sadaka","year":"2016","journal-title":"Clin Ophthalmol"},{"key":"R53-20250819","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/ICB.0000000000001359","article-title":"Rhegmatogenous retinal detachment with concurrent choroidal detachment and macular hole formation after uncomplicated cataract extraction and intraocular lens implantation: a case report and review of literature","volume":"18","author":"Tsui","year":"2024","journal-title":"Retin Cases Brief Rep"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004565","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T15:00:53Z","timestamp":1755615653000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":53,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004565","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"type":"print","value":"0275-004X"},{"type":"electronic","value":"1539-2864"}],"subject":[],"published":{"date-parts":[[2025,9]]}}}